Vimarsana
Biggest News Aggregation in the World

Page 15 - Akili Interactive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akili Interactive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akili Interactive Today - Breaking & Trending Today

ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic Therapeutics with $75 Million in Series A Funding - Vimarsana News

ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic Therapeutics with $75 Million in Series A Funding

/PRNewswire/ -- ATP, a leader in life sciences venture capital, today debuted Intergalactic Therapeutics, a non-viral gene therapy platform led by a top...

Intergalactic Therapeutics launches with $75M to build a new type of gene therapy - Vimarsana News

Intergalactic Therapeutics launches with $75M to build a new type of gene therapy

BioPharma

How four-person startup Luminopia is using TV to treat lazy eye  – TechCrunch - Vimarsana News

How four-person startup Luminopia is using TV to treat lazy eye  – TechCrunch

If you’re diagnosed with lazy eye — otherwise known as amblyopia — as a child, there are only a few options at your disposal. You can wear an eye patch, you can take eye drops or you can wear corrective lenses. Or, in the future (pending FDA clearance), you could watch TV.  That’s the central […]

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: Akili Deal Furthers Digital Medicine Leadership - Vimarsana News

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: Akili Deal Furthers Digital Medicine Leadership

Investegate announcements from PureTech Health PLC, Akili Deal Furthers Digital Medicine Leadership

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green - Vimarsana News

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green | Financial News

Source: lse.co.uk